Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

Astellas receives further year suspension from ABPI

June 26, 2017 Medical Communications, Sales and Marketing ABPI, Astellas

The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …
News

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017 Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …
News
novartis_outside_1

Novartis lung cancer combo receives FDA approval

June 23, 2017 Medical Communications, Sales and Marketing NSCLC, Novartis

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …
News
needle-1291170_960_720

HIV cases in gay men fall for the first time in England

June 23, 2017 Medical Communications HIV, PrEP

For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …
News
shutterstock_187433765

Rare cancers through the looking glass

June 23, 2017 Medical Communications, Research and Development pharmafile, rare cancer

Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …
News

FDA’s Gottlieb draws those ‘gaming’ system into pricing debate

June 22, 2017 Medical Communications, Sales and Marketing Drug pricing, FDA, Trump

President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …
News

Thermo Fisher Scientific announces single quadrupole mass spectrometer and specialised columns

June 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …
News
Press release

Making strides in hepatitis

June 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson & Johnson

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …
News

Shooting for the moon: The National Cancer Institute’s Formulary

June 16, 2017 Medical Communications, Research and Development NCI

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …
News
sunbathing-1207930_960_720

Drug that induces tanning could protect against melanoma

June 16, 2017 Medical Communications, Research and Development melanoma, skin cancer, sun

People will often go to extraordinary lengths to achieve tanned skin but researchers have found a potential method that does …
News
bicycle_therapeutics

Cambridge start-up secures £40 million to trial innovative cancer drugs

June 16, 2017 Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer

Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …
News
fda_sign_web

New rival to EpiPen receives FDA approval to shake up market

June 16, 2017 Medical Communications, Sales and Marketing Adamis, Mylan, Symjepi, epipen

Adamis Pharmaceuticals has revealed that it received FDA approval for its EpiPen rival to enter the market. Its product, to …
News
roche__tree

From pipeline to patients: Navigating treatments through the UK system

June 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline

Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …
Feature
The Gateway to Local Adoption Series

Latest content

NICE backs atogepant for acute migraine treatment

June 12, 2026

Survey data highlight challenges in anaphylaxis treatment adherence

June 11, 2026

Hansa Biopharma appoints Fredrik Röök as VP Business Development

June 11, 2026

Sofinnova and AWS collaborate on AI tools for life sciences

June 10, 2026

First European approval given to non-opioid treatment for chronic low back pain

June 9, 2026